Christopher Ryan Sullivan
CIK 1810417 · Chief Financial Officer · last filed 2026-06-12
Christopher Ryan Sullivan is a Chief Financial Officer who has filed 24 SEC Form 4 insider transactions across 2 companies since 2020. The most recent filing shows the insider had shares withheld for taxes covering $1.8K of AVTX on Jun 12, 2026. Across all open-market trades the lifetime net is −$1.9M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $795.9K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$795.9K
2
24
-$1.87M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| AVTX | Chief Financial Officer | 40,773 | $19.52 | $795.9K | -$1.89M | 17 | 2026-06-12 |
| Avalo Therapeutics, Inc. (CERC) Delisted | Interim CFO | 8,049 | $2.93 | $23.6K | $18.3K | 3 | 2021-01-28 |
Recent Filings
24 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-12 | AVTX | Tax (F) | −138 | -$1.8K | EDGAR |
| 2026-05-26 | AVTX | Grant (A) | +39,900 | $0 | EDGAR |
| 2026-05-11 | AVTX | Mixed | — | -$265.0K | EDGAR |
| 2026-05-07 | AVTX | Notice (144) | −18,606 | -$405.8K | EDGAR |
| 2026-05-07 | AVTX | Mixed | — | -$570.8K | EDGAR |
| 2026-05-06 | AVTX | Notice (144) | −47,000 | -$764.2K | EDGAR |
| 2026-05-01 | AVTX | Sell (S) | −16,915 | -$222.6K | EDGAR |
| 2026-04-29 | AVTX | Notice (144) | −16,915 | -$217.5K | EDGAR |
| 2026-04-03 | AVTX | Sell (S) | −15,959 | -$270.6K | EDGAR |
| 2026-04-01 | AVTX | Notice (144) | −15,959 | -$238.3K | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.